MetLife Introduces Cancer Support Benefit to Aid Employees in Cancer Diagnosis and Treatment

Strategic Insights -

MetLife has announced the launch of a new Cancer Support benefit, designed to provide personalized advice and attention to employees diagnosed with cancer. The benefit, developed in partnership with Private Health Management, aims to offer comprehensive care navigation, expert-led coordination, and patient counseling to help individuals navigate the complexities of cancer treatment and recovery. This move comes as new cancer cases are expected to rise to over two million in 2025, with one in every three Americans likely to develop cancer in their lifetime.

Key Takeaways:

  • The Cancer Support benefit will provide employees with access to top oncology specialists, tech-enabled coordination, and patient counseling, helping to improve patient outcomes and reduce medical costs.
  • Employers who have utilized Private Health Management's services have seen significant outcomes, including a 20% reduction in average cost per case managed and a 2-4 times improvement in survival for late-stage cancers.
  • The benefit is designed to provide a clearer path forward for patients and their families, reducing financial hardship and medical costs.
  • Private Health Management's team of experienced professionals will work closely with MetLife to provide individualized counseling and attention to covered policyholders.
  • The Cancer Support benefit is part of MetLife's commitment to building a comprehensive benefits experience for employees.

Statistics:

  • New cancer cases are expected to rise to over two million in 2025 (Source: [1]).
  • One in every three Americans will develop cancer in their lifetime (Source: [1]).
  • Those impacted by cancer are 71% more likely to face financial hardship within two years of diagnosis (Source: [2]).
  • Cancer costs are projected to rise 34% between 2015 and 2030 (Source: [2]).
  • Employers who have deployed Private Health Management services have seen a 20% reduction in average cost per case managed (Source:
  • 15% of unnecessary treatments have been avoided (Source: ).